Bemotrizinol: The New Sunscreen Ingredient Changing SPF in 2026

Your sunscreen is about to get a serious upgrade, and it only took the FDA 20 years to sign off on it.

In June, the agency approved bemotrizinol, the first new sunscreen ingredient greenlit for the U.S. market since the 1990s. If you’ve ever slathered on a European or Korean sunscreen and wondered why it felt so much lighter than the stuff on American shelves, this is basically that same magic finally coming stateside. Before this approval, the U.S. had 16 approved active sunscreen ingredients compared to roughly 30 in Europe, and dermatologists have spent years watching the gap widen.

So what’s actually different, which brands are getting it first, and does this mean you can finally toss that chalky white sunscreen that makes you look like a ghost at the beach? Let’s get into it.

What Is Bemotrizinol, Exactly?

Bemotrizinol is a chemical UV filter that absorbs both UVA and UVB radiation, the two types of ultraviolet rays responsible for sunburn, premature aging, and skin cancer. That “both in one” part matters more than it sounds. Most chemical filters currently sold in the U.S. are specialists. Under current FDA rules, available chemical ingredients only protect against UVA or UVB, not both, so companies blend multiple chemicals together to get full-spectrum coverage.

Bemotrizinol does the job solo, and does it well. Dermatology and environmental health experts note it’s highly photostable, meaning it doesn’t break down when hot summer sun hits your skin, unlike avobenzone, which until now was the only non-mineral filter sold in the U.S. that offered meaningful UVA coverage. Translation: your SPF actually holds up during that third hour poolside, not just the first 90 minutes.

You may already recognize this ingredient by another name. It’s been sold across Europe and Asia for decades under names like Tinosorb S and BEMT, and if you’ve ever bought sunscreen abroad, there’s a decent chance you’ve already used it without knowing.

Why the FDA Took So Long

Short answer: bureaucracy. In the U.S., sunscreens are regulated as over-the-counter drugs rather than cosmetics like they are in Europe, which means ingredients need extensive safety and efficacy testing before approval. Manufacturer DSM-Firmenich reportedly spent at least $18 million over more than two decades pushing bemotrizinol through the FDA pipeline. That’s not a typo. Two decades. For sunscreen.

The upside of that painfully slow process: bemotrizinol now has more safety data behind it than any other chemical sunscreen ingredient currently approved in the U.S., according to EWG senior scientist Alexa Friedman. Animal testing showed no signs of reproductive harm, and human clinical testing found it doesn’t irritate skin, even with repeated use.

Which Brands Are Getting It First

Here’s the part that’s going to frustrate the “I want it now” crowd. DSM-Firmenich holds exclusive U.S. marketing rights to bemotrizinol for 18 months, and the ingredient will initially only appear under DSM’s own brand, Parsol Shield. Companies can legally start incorporating bemotrizinol into products beginning Aug. 9, 2026, but the first bemotrizinol sunscreens realistically may not hit shelves until late 2026 or even 2027, once formulation, testing and packaging catch up to the approval.

After that exclusivity window closes, expect the floodgates to open. Major names like Coppertone and Banana Boat have been asked about their plans, though nothing’s confirmed publicly yet. Once other manufacturers can legally use bemotrizinol, dermatologists are predicting a genuine wave of reformulated SPF products, not just a niche release.

Who Benefits Most From This Ingredient

Sensitive Skin and Babies

Bemotrizinol may become the first chemical UV filter recommended for use on infants, thanks to its minimal skin irritation, according to Dr. Nisha Varadarajan, a dermatologist at Memorial Sloan Kettering Cancer Center. That would make it only the third sunscreen ingredient considered safe for children 6 months and older, joining zinc oxide and titanium dioxide.

Anyone Who Hates White Cast

Bemotrizinol can be combined with zinc oxide to deliver strong broad-spectrum protection with less white cast than mineral-only formulas, per Friedman. If you’ve avoided mineral sunscreen because you don’t want to look ashy in photos, this pairing is aimed directly at you.

The Bigger Picture: Skin Cancer Numbers Don’t Lie

This isn’t just a beauty-aisle upgrade. Skin cancer remains the most commonly diagnosed cancer in the U.S., claiming more than one life every hour, with over 200,000 new melanoma cases estimated for 2026, according to the Melanoma Research Foundation. Traditional U.S. sunscreens have historically excelled at blocking UVB rays that cause visible sunburn but routinely fall short protecting against deep-penetrating UVA rays, which drive both aging and cancer risk. Closing that UVA gap is the entire point of this approval.

How to Use Sunscreen Correctly (New Ingredient or Not)

Whatever’s in your bottle this summer, the fundamentals haven’t changed:

• Go broad-spectrum, SPF 30 or higher. Anything less isn’t doing the UVA job.
• Use about an ounce for full-body coverage. That’s a shot glass worth, not a dab.
• Apply 15 minutes before sun exposure, so it has time to actually bind to skin.
• Reapply every two hours, and immediately after swimming or heavy sweating, regardless of how “water resistant” the label claims.
• Don’t skip ears, neck, hands and the part in your hair. These are the most commonly missed zones, and also common melanoma sites.

Bemotrizinol’s photostability might buy you a little wiggle room on that two-hour rule, but no dermatologist is telling you to skip reapplication entirely.

The Bottom Line

Bemotrizinol won’t be sitting on shelves in every drugstore very soon, but its approval marks the first real shakeup in U.S. sun care in a generation. Parsol Shield gets first dibs this year, with wider brand adoption expected once the exclusivity window closes in 2027. Until then, keep doing what actually works: broad-spectrum SPF 30-plus, applied generously and reapplied often. The best sunscreen is still the one you’ll actually wear correctly.

---

5. FAQ

What is bemotrizinol?
Bemotrizinol is a chemical UV filter that protects against both UVA and UVB rays in a single ingredient. It’s newly approved by the FDA but has been used internationally for decades under names like Tinosorb S and BEMT.

When did the FDA approve bemotrizinol?
The FDA approved bemotrizinol on June 9, 2026, marking the first new sunscreen active ingredient approved in the U.S. in more than two decades.

What sunscreen brand will have bemotrizinol first?
DSM-Firmenich holds exclusive U.S. rights to market bemotrizinol for 18 months under the brand name Parsol Shield. Other manufacturers can begin using the ingredient after that exclusivity period ends.

Is bemotrizinol safe for babies?
Early reporting suggests bemotrizinol may become the first chemical sunscreen filter recommended for infants due to its low irritation profile, though parents should always check current pediatric guidance before use.

Is bemotrizinol better than my current sunscreen?
It offers broader, more stable UVA and UVB protection in one ingredient and tends to feel lighter on skin, but any broad-spectrum SPF 30+ sunscreen applied correctly still provides solid protection.